Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Antibodies, Neutralizing"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Duan%2C+Kai%22&type=Person&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Neutralizing%22
/vufind/Search/Results?lookfor=%22Duan%2C+Kai%22&type=Person&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Neutralizing%22
Search /vufind/Search2/Results?lookfor=%22Duan%2C+Kai%22&type=Person&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Neutralizing%22
PubPharm (9)
1
Human monoclonal antibody F61 nasal spray effectively protected high-risk populations from SARS-CoV-2 variants during the COVID-19 pandemic from late 2022 to early 2023 in China
enthalten in:
Emerging microbes & infections
| 2024
von
Liu, Y.
|
Zhang, J.
|
Liu, W.
| +20
Wird geladen...
2
Safety and immunogenicity of rabies vaccine (PVRV-WIBP) in healthy Chinese aged 10-50 years old : Randomized, blinded, parallel controlled phase III clinical study
enthalten in:
Human vaccines & immunotherapeutics
| 2023
von
Huang, X.
|
Liang, J.
|
Huang, L.
| +18
Wird geladen...
3
Clinical evaluation of the lot-to-lot consistency of an enterovirus 71 vaccine in a commercial-scale phase IV clinical trial
enthalten in:
Human vaccines & immunotherapeutics
| 2022
von
Chen, J.
|
Jin, P.
|
Chen, X.
| +19
Wird geladen...
4
Nasal delivery of broadly neutralizing antibodies protects mice from lethal challenge with SARS-CoV-2 delta and omicron variants
enthalten in:
Virologica Sinica
| 2022
von
Lu, J.
|
Yin, Q.
|
Pei, R.
| +18
Wird geladen...
5
Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children : Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial
enthalten in:
Frontiers in immunology
| 2022
von
Xia, S.
|
Duan, K.
|
Zhang, Y.
| +35
Wird geladen...
6
Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan
enthalten in:
Nature communications
| 2021
von
Li, C.
|
Yu, D.
|
Wu, X.
| +33
ErratumIn: Nat Commun. 2021 Aug 5;12(1):4846. - PMID 34354086
Wird geladen...
7
The Antigenicity of Epidemic SARS-CoV-2 Variants in the United Kingdom
enthalten in:
Frontiers in immunology
| 2021
von
Wu, J.
|
Zhang, L.
|
Zhang, Y.
| +11
Wird geladen...
8
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes : Interim Analysis of 2 Randomized Clinical Trials
enthalten in:
JAMA
| 2020
von
Xia, S.
|
Duan, K.
|
Zhang, Y.
| +34
CommentIn: JAMA. 2020 Sep 8;324(10):943-945. - PMID 32789500
Wird geladen...
9
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
enthalten in:
Proceedings of the National Academy of Sciences of the United States of America
| 2020
von
Duan, K.
|
Liu, B.
|
Li, C.
| +45
CommentIn: Proc Natl Acad Sci U S A. 2020 Jun 9;117(23):12526-12527. - PMID 32398378
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Antibodies, Neutralizing
Medienart
9
Aufsätze
9
E-Artikel
9
E-Ressourcen
Zeitschriftentitel
2
Frontiers in immunology
2
Human vaccines & immunotherapeutics
1
Emerging microbes & infections
1
JAMA
1
Nature communications
1
Proceedings of the National Academy of Sciences...
1
Virologica Sinica
Alle anzeigen ...
weniger ...
Thema
Antibodies, Neutralizing
9
Journal Article
8
Antibodies, Viral
5
Randomized Controlled Trial
5
Research Support, Non-U.S. Gov't
3
COVID-19 Vaccines
3
Spike Glycoprotein, Coronavirus
3
immunogenicity
3
safety
3
spike protein, SARS-CoV-2
2
Antibodies, Monoclonal
2
Broadly Neutralizing Antibodies
2
COVID-19
2
Clinical Trial, Phase I
2
Clinical Trial, Phase II
2
SARS-CoV-2
2
Vaccines, Inactivated
2
monoclonal antibody
1
5QB0T2IUN0
1
6RC3ZT4HB0
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1
2024
1
2023
3
2022
2
2021
2
2020
Alle anzeigen ...
weniger ...
Erscheinungsjahr(e)
Von:
Bis:
Sprache
9
Englisch
Haven't found what you're looking for?
Wird geladen...